Lennard is a partner in De Brauw’s Corporate/M&A practice, and head of the private equity practice. He acts for Dutch and international private equity firms on their acquisitions and exit transactions, as well on other matters throughout the investment period. In addition, Lennard regularly acts for founders and family-owned companies who wish to sell their company or to partner with private equity. He is often consulted for his expertise in governance arrangements between shareholders, private equity funds and co-investors, including minority investments by private equity, and in warranty & indemnity insurance and management participation plans.

Lennard is recognised as a leader in his field, as also confirmed by Legal 500 (‘Hall of Fame’ for Private Equity) and Chambers. Lennard was nominated as one of six lawyers for the Dutch Best M&A Lawyer Award each year as from 2020 and won the award in 2021 and 2023.

Lennard played an important role in establishing De Brauw’s Singapore office.

Lennard’s recent work includes advising:

• Bain Capital on the sale of Bugaboo to Mubadala Capital (and its reinvestment)
• Ardian on the acquisition of Attero from 3i and DWS
  
• SHV on the sale of ERIKS to Lonestar
  
• The founders of Schuberg Philis on the sale of a majority stake to Bridgepoint
• VolkerWessels on the sale of their Energy, Telecom and Technical Installation business to Triton
  
• Deutsche Telekom on the EUR 5.1 billion sale of T-Mobile Netherlands to Apax and Warburg Pincus
  
• Parcom on most of its acquisitions and divestments since 2016, including the acquisition of Hunkemöller, Wajer Yachts , Zorg van de Zaak, Group of Butchers, Simpel.nl, Yource, MGG Group, ConDoor Group, Koninklijke Euroma, NedacSorboMascot, Outdoor Life Group, Viroclinics and other portfolio companies, and the sale of Altrex, Jan Snel, ConDoor Group, GustoMSC, GoodHabitz, Climate for Life, Viroclinics and various other transactions
  
• BlackFin on the acquisition of the personal lines brokerage and MGA business of Aon Netherlands
• G Square on the sale of the Duomed group to Palex Medical and several of their other healthcare transactions
• Vortex Capital and the founder of hallo, group on the sale of a majority stake to KLAR
  
• Advent and Unit4 on the sale of the Unit4 Dutch software business to Exact Group and various other transactions, including the sale of Unit4 to TA Associates and Partners Group
• Several undisclosed dental transactions
• General Atlantic on the acquisition of GRESB from Summit
• Rivean Capital on the acquisition of Valcon, CED, Eichholtz, Muon and a majority stake in EDCO, and on the sale of Muon Group to IDEX
  
• The founder of YER on the sale of a minority stake to Inflexion
  
• The founder of De Jong Packaging on the sale to Stora Enso
  
• The founder of the Scheybeeck group on the sale of a majority stake in BUKO Infrasupport and BUKO Waakt to Equistone
  
• The Kloosterboer family on the sale of Kloosterboer Group to Lineage (Bay Grove)
  
• BC partners on the sale of Pharmathen for an enterprise value of approximately EUR 1.6 billion
• Triton on the acquisition of a majority stake in Bergman Clinics as well as Royal Reesink
• Nordian Capital on the sale of BauWatch Group to Haniel
  
• T-Mobile Netherlands on the acquisition of Simpel.nl, and Deutsche Telekom and T-Mobile Netherlands on the acquisition of Tele2 Netherlands
  
• The founders of IG&H on the sale of a majority stake to IK Partners
• Summit Partners and the founder on the sale of Normec to Astorg (2020), and the sale to an Astorg continuation fund (2024)
  
• The founders of Topicus on the sale to TSS / CSI
  
• The founders of Acture Group on the sale to IK Investments
  
• The founder of 247Tailorsteel on the sale of a majority stake to Parcom
  
• Synthon Generics' management on the MIP with BC Partners
  
• Bain Capital on the acquisition of Bugaboo from the founders